[1]Institute of Medicine (US) Committee on Standards for Systematic Reviews of Comparative Effectiveness Research. Finding What Works in Health Care: Standards for Systematic Reviews[M]. Washington (DC): National Academies Press (US), 2011,Avaiable from:Https://www.nibi,nlm.nih.gov/books/NBK 209525.
[2]Elliott JH, Turner T, Clavisi O, et al. Living systematic reviews: an emerging opportunity to narrow the evidence-practice gap[J]. PLoS Med, 2014, 11(2): e1001603.
[3]Sampson M, Shojania KG, Garritty C, et al. Systematic reviews can be produced and published faster[J]. J Clin Epidemiol, 2008, 61(6): 531-536.
[4]Bragge P, Clavisi O, Turner T, et al. The global evidence mapping initiative: scoping research in broad topic areas[J]. BMC Med Res Methodol, 2011, 11(92): 1-12.
[5]Elliott JH, Synnot A, Turner T, et al. Living Systematic Review Network. Living systematic review: 1. Introduction-the why, what, when, and how[J]. J Clin Epidemiol,2017, 91: 23-30.
[6]Cochrane Community. Living systematic reviews[EB/OL].[2021-09-15]: https://community.cochrane.org/review-production/production-resources/living-systematic-reviews#network.
[7]Thomas J, Noel-Storr A, Marshall I, et al. Living systematic reviews: 2. Combining human and machine effort[J]. J Clin Epidemiol, 2017, 91: 31-37.
[8]Simmonds M, Salanti G, McKenzie J, et al. Living systematic reviews: 3. Statistical methods for updating meta-analyses[J]. J Clin Epidemiol, 2017, 91: 38-46.
[9]邱均平. 信息计量学(九)第九讲文献信息引证规律和引文分析法[J]. 情报理论与实践,2001, 24(3): 236-240.
[10]Gao Y, Shi S, Ma W, et al. Bibliometric analysis of global research on PD-1 and PD-L1 in the field of cancer [J]. Int Immunopharmacol, 2019, 72: 374-384.
[11]Chen CM. CiteSpace 5. 7. R2 Ⅱ: detecting and visualizing emerging trends and transient patterns in scientific literature [J]. J American Society for Information Science and Technology, 2006, 57(3): 359-377.
[12]康迎英, 张福利, 蔡润津, 等. 基于VOSviewer国外医药卫生领域计算机辅助教学研究计量学分析[J]. 中国医药导刊, 2019, 21(3): 181-187.
[13]Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China [J]. N Engl J Med,2020,382(18): 1708-1720.
[14]Sterne JAC, Savovi c′ J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials [J]. BMJ, 2019, 366: l4898.
[15]刘明, 高亚, 胡志伟, 等. 全球卫生技术评估研究引文科学知识图谱分析[J]. 中国药物评价, 2020, 37(5): 341-348.
[16]兰小筠, 唐君波, 张燕舞, 等. SCIENCE 2000年载文统计分析[J]. 中国科技期刊研究, 2002, 13(3): 192-194.
|